Status:
COMPLETED
Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis
Lead Sponsor:
Assiut University
Conditions:
Psoriasis Vulgaris
Fractional CO2 Laser
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
comparing the clinical efficacy of topical ointment containing calcipotriol and betamethasone dipropionate used alone with the simultaneous use of fractional carbon dioxide laser and the same topical ...
Detailed Description
Psoriasis is a widespread, persistent papulosquamous skin condition that can affect anyone at any age and places a heavy strain on both the individual and society. It is linked to a number of serious ...
Eligibility Criteria
Inclusion
- Patients with chronic plaque psoriasis of either sex.
- Aged more than 18 years of age.
Exclusion
- Pregnant and lactating women.
- Patients with severe skin infection.
- Patients who are under systemic ttt or phototherapy in the last 3 months.
- Immunosuppression or being under any kind of treatment causingabsolute or relative immunosuppression
- History of any bleeding, clotting disorder or using anticoagulants.
- Chronic systemic diseases such as chronic renal failure, hepatic insufficiency, and cardiovascular disorders.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06011083
Start Date
August 1 2022
End Date
August 1 2023
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71511